DiaMedica Therapeutics Inc — Balance Sheet (NASDAQ:DMAC) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Total assets 28.09 M45.55 M34.4 M54.16 M46.34 M Total liabilities 2.08 M1.53 M2.57 M3.1 M5.63 M Total equity 26.01 M44 M31.8 M51.1 M40.7 M Total liabilities & shareholders' equities 28.09 M45.55 M34.4 M54.16 M46.34 M Total debt ————— Net debt —————

Nachrichten

Cantor Fitzgerald bestätigt "Overweight"-Rating für DiaMedica-Aktie

Cantor Fitzgerald reiterates Overweight rating on DiaMedica stock

DiaMedica: Zusätzliche Studie für Präeklampsie-Wirkstoff nach FDA-Gespräch erforderlich

DiaMedica to conduct additional study for preeclampsia treatment

Cisco, Flutter, Manulife and more set to report earnings Wednesday

TD Cowen startet Coverage für DiaMedica mit Kaufempfehlung

DiaMedica Therapeutics stock initiated with Buy rating at TD Cowen

Tracking Leon Cooperman’s ~$3B Omega Advisors Portfolio – Q2 2025 Update

DiaMedica Therapeutics, Inc. (DMAC) is a Great Momentum Stock: Should You Buy?

After Golden Cross, DiaMedica Therapeutics, Inc. (DMAC)'s Technical Outlook is Bright

Wall Street Analysts Believe DiaMedica Therapeutics (DMAC) Could Rally 100.81%: Here's is How to Trade

What Makes DiaMedica Therapeutics, Inc. (DMAC) a Strong Momentum Stock: Buy Now?